Study identifier:D9603R00004
ClinicalTrials.gov identifier:NCT05548777
EudraCT identifier:N/A
CTIS identifier:N/A
Andexanet alfa and 4F-PCC use in patients hospitalised with an anticoagulant-related major bleed
Anticoagulant-related major bleed
N/A
No
Andexanet alfa, 4F-PCC
All
5480
Observational
18 Years - 130 Years
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2023 by AstraZeneca
AstraZeneca
Outcomes Insights
No locations available
Arms | Assigned Interventions |
---|---|
Patients hospitalized for an anticoagulation-related major bleed | - |